Press Event - IMI announces 8 new projects

Start Date 08/03/2011

IMI announced 8 new projects at a Press Briefing in Brussels on 8 March 2011, bringing the number to a total of 23 unique IMI projects to boost drug innovation. Over 30 members of the press and media joined Michel Goldman, Executive Director of IMI to hear about the 8 new second-wave projects and to hear how the 15 first-wave projects were performing.

Michel Goldman opened the event and EFPIA member, Roch Doliveux (UCB) provided the EFPIA industry view on the new projects being launched. After a round-table presentation of the 8 IMI projects, David Henderson (Bayer Schering Pharma), Herman Goossens (University of Antwerp), Peter Andersen (Lundbeck) and Breda Flood (European Federation of Allergy and Airways Diseases Patients' Associations) presented their perspective on participating in an IMI project. Further opportunities for members of the press and media to talk to the speakers were provided during a walking lunch.

Coverage of IMI and its new projects included articles in the British Medical Journal, La Libre Belgique, BioWorld and Science Business newswire services.